Fertility concerns, explained clearly

PCOS & Ovulatory Irregularities

Affects approximately 1 in 5 women of reproductive age in India

Polycystic Ovary Syndrome (PCOS) is a common endocrine and metabolic condition characterised by hormonal imbalances, irregular or absent menstrual periods, and ovaries containing multiple small, immature follicles. While PCOS is one of the most frequent causes of anovulatory infertility, evidence-based reproductive care offers multiple gentle and effective pathways toward conception.

Care pathways to discuss

What people commonly notice

• Irregular, infrequent, or absent menstrual periods (oligomenorrhoea or amenorrhoea)
• Signs of elevated androgens such as persistent acne, facial hair (hirsutism), or hair thinning
• Difficulty tracking natural ovulation windows with standard home predictor kits
• Metabolic symptoms including insulin resistance, weight fluctuations, or fatigue

How it affects conception

• Anovulation: eggs fail to mature or release regularly from ovarian follicles
• Asynchronous hormonal signalling between LH and FSH, disrupting endometrial receptivity
• Subtle egg quality variations associated with hyperinsulinaemia and local inflammatory markers

Investigations usually recommended

• Pelvic ultrasound evaluation, checking ovarian morphology and antral follicle patterns
• Baseline hormonal profile: LH, FSH, oestradiol and prolactin
• Serum AMH (Anti-Müllerian Hormone) test, often elevated in PCOS
• Metabolic screen: fasting glucose, insulin levels and lipid profile

Endometriosis & Pelvic Factors

Present in up to 35–50% of women navigating fertility challenges

Endometriosis occurs when tissue resembling the uterine lining (endometrium) grows outside the uterus — most commonly on the ovaries (endometriomas, or chocolate cysts), fallopian tubes, and pelvic peritoneum. This tissue responds to menstrual cycles, causing localised inflammation, scarring and anatomical distortion that can affect conception.

Care pathways to discuss

What people commonly notice

• Severe pelvic pain or cramping during periods (dysmenorrhoea)
• Deep discomfort during or after intercourse (dyspareunia)
• Chronic lower back pain or pelvic heaviness outside of menstrual cycles
• Occasional painful urination or bowel movements during menstruation

How it affects conception

• Pelvic adhesions and distorted anatomy altering the natural egg pick-up mechanism of the fallopian tubes
• A chronic pelvic inflammatory environment compromising egg quality and sperm-egg binding

Investigations usually recommended

• High-resolution transvaginal ultrasound by an experienced fertility specialist
• Serum AMH test to assess baseline ovarian reserve before any surgical intervention
• Diagnostic pelvic MRI in complex deep infiltrating endometriosis cases
• Laparoscopic evaluation where clinically indicated

Low AMH & Diminished Ovarian Reserve

Frequently diagnosed in women over 35, but also found in younger individuals

Anti-Müllerian Hormone (AMH) is produced by granulosa cells in growing ovarian follicles, serving as a proxy for the remaining quantity of eggs. A low AMH level indicates diminished ovarian reserve, meaning fewer eggs remain. It is important to understand that AMH indicates egg quantity, not egg quality, and pregnancy is achievable with tailored clinical protocols.

Care pathways to discuss

What people commonly notice

• Gradually shortening menstrual cycles, for example from 28 days down to 24 or 25 days
• Lighter menstrual bleeding over consecutive months
• Often completely asymptomatic, and only detected on baseline fertility screening
• Occasional hot flushes or night sweats in advanced ovarian decline

How it affects conception

• Fewer follicles respond during an ovarian stimulation cycle
• A narrower window of time in which to conceive, warranting proactive timelines
• Higher likelihood of cycle cancellation if standard high-dose protocols are inappropriately applied

Investigations usually recommended

• Serum AMH blood test, which is stable across any day of the menstrual cycle
• Day 2/3 antral follicle count (AFC) via high-resolution pelvic ultrasound
• Baseline Day 2 FSH and oestradiol, to evaluate pituitary feedback mechanisms

Blocked Fallopian Tubes & Pelvic Factors

Accounts for 25–30% of all female fertility diagnoses

Fallopian tubes play an indispensable role in natural conception: they pick up the released egg, provide the site for natural fertilisation, and transport the early embryo to the uterus. If tubes are blocked, scarred, or swollen with fluid (hydrosalpinx), natural conception is physically prevented. IVF was originally developed specifically to overcome tubal factor infertility.

Care pathways to discuss

What people commonly notice

• Typically asymptomatic, without any visible warning signs in simple blockages
• Mild persistent lower abdominal ache in cases of bilateral hydrosalpinx
• A history of pelvic inflammatory disease, previous ruptured appendix, or abdominal surgery

How it affects conception

• Physical obstruction preventing sperm from reaching and fertilising the egg
• Hydrosalpinx fluid may leak back into the uterine cavity, creating a hostile environment for implantation
• Increased risk of ectopic pregnancy if partially patent tubes trap the dividing blastocyst

Investigations usually recommended

• Hysterosalpingography (HSG): a fluoroscopic dye X-ray checking tubal patency and contour
• Hystero-contrast-salpingography (HyCoSy): a gentle ultrasound-based dye assessment
• Diagnostic laparoscopy with chromopertubation in complex cases

Male Factor Infertility & Sperm Health

Contributes to 40–50% of all couple fertility challenges

Male fertility is an equal and vital component of conception. Parameters including sperm concentration (count), progressive motility (swimming ability), morphology (cellular shape), and DNA fragmentation directly affect fertilisation and embryo viability. Modern andrology and embryology offer precise, dignified diagnostic and therapeutic options.

Care pathways to discuss

What people commonly notice

• Rarely causes outward symptoms; sexual drive and performance are typically normal
• Occasional scrotal heaviness or dull ache, indicating a potential varicocele
• A history of undescended testicles, mumps orchitis, or groin trauma
• Past exposure to high testicular temperatures, smoking, or occupational toxins

How it affects conception

• Oligospermia (low count), reducing the number of sperm reaching the fallopian tube
• Asthenospermia (poor motility), preventing sperm from penetrating the zona pellucida
• An elevated sperm DNA Fragmentation Index (DFI), leading to early developmental arrest or miscarriage

Investigations usually recommended

• Computer-assisted semen analysis (CASA), calibrated to WHO 6th edition guidelines
• Sperm DNA Fragmentation Index (DFI), to evaluate genetic structural integrity
• Scrotal Doppler ultrasound, to evaluate testicular volume and rule out varicocele
• Endocrine hormonal profile: FSH, LH, total testosterone and prolactin

Unexplained Infertility

Diagnosed in approximately 15–25% of couples seeking fertility assistance

A diagnosis of unexplained infertility is made when standard investigations — ovulation assessment, semen analysis, and tubal patency tests — show normal results, yet pregnancy has not occurred naturally after 12 or more months of regular unprotected intercourse. Unexplained does not mean untreatable; subtle cellular barriers often reveal themselves only within an advanced embryology environment.

Care pathways to discuss

What people commonly notice

• Regular, predictable menstrual cycles with confirmed monthly ovulation
• Normal semen analysis parameters under routine laboratory testing
• Clear, open fallopian tubes with no visible uterine pathology
• Frustration arising from uninformative standard diagnostic results

How it affects conception

• Undiagnosed sperm-egg binding deficiencies or zona pellucida penetration barriers
• Occult sperm DNA fragmentation not detected by basic semen testing
• Subtle endometrial-embryo communication mismatches during the implantation window

Investigations usually recommended

• Second-look detailed semen analysis, including sperm DNA Fragmentation Index (DFI)
• Assessment of timing, frequency and luteal phase progesterone adequacy
• High-resolution ultrasound assessing endometrial triple-line pattern and blood flow
• Review of previous treatment cycles and follicular tracking history

Recurrent Pregnancy Loss (RPL)

Experienced by 1–2% of couples attempting pregnancy

Recurrent pregnancy loss is clinically defined as the loss of two or more consecutive pregnancies. It is a profoundly emotional medical challenge requiring sensitive, comprehensive investigation into parental genetics, uterine cavity structure, thrombophilic factors, endocrine balance and sperm DNA integrity.

Care pathways to discuss

What people commonly notice

• Two or more documented miscarriages or chemical pregnancies
• A normal ability to conceive initially, but difficulty carrying to term
• Emotional exhaustion and anxiety surrounding subsequent positive pregnancy tests

How it affects conception

• Chromosomal aneuploidies in the developing embryo account for the majority of early losses
• Uterine anatomical variations, such as a uterine septum, submucosal fibroids, or Asherman adhesions
• Maternal thrombophilias such as antiphospholipid syndrome, causing micro-clots in placental vessels

Investigations usually recommended

• Parental karyotyping, to detect balanced chromosomal translocations in either partner
• 3D pelvic ultrasound or hysteroscopy, to examine the uterine cavity architecture
• Antiphospholipid antibody panel: lupus anticoagulant, anticardiolipin and anti-beta2-GP1
• Sperm DNA Fragmentation Index (DFI), to evaluate the paternal genetic contribution

Age-Related Fertility Considerations

Increasingly common as more couples choose family building in their 30s and 40s

A woman is born with all the eggs she will ever possess. As time passes, both the quantity (ovarian reserve) and the chromosomal normality of eggs naturally decline. Understanding this physiological timeline allows couples to make informed, proactive decisions without panic, using modern reproductive science to optimise every cycle.

Care pathways to discuss

What people commonly notice

• Age over 35, attempting conception for six months without success
• A gradual decrease in menstrual volume or cycle length
• Previous unsuccessful timed intercourse or IUI attempts

How it affects conception

• A higher proportion of retrieved eggs with chromosomal non-disjunction (aneuploidy)
• Lower response to hormonal stimulation medication, requiring individualised dosing
• A higher baseline rate of early pregnancy loss in unassisted conception

Investigations usually recommended

• Baseline AMH and Day 2/3 antral follicle count, to gauge reserve accurately
• Day 2 FSH and oestradiol, to evaluate ovarian responsiveness
• Comprehensive semen analysis for the male partner, as paternal age also affects sperm parameters